Why has it taken 20 years to approve the new Alzheimer’s drug?
Two weeks ago a new drug to treat Alzheimer’s disease was given accelerated approval by the US Food and Drug Administration. The drug is called aducanumab, commercially…
Tag: Dementia
Is the ‘breakthrough’ Alzheimer’s drug approved by the FDA too good to be true?
A promising agent to tackle dementia has been filed for approval in Australia, but another trial is pending.
COVID-19 pandemic ‘accelerating decline’ for patients with dementia
Disrupted routine and delayed medical visits will take a toll, geriatrician warns.
Social prescribing ‘beats drugs’ for depression in dementia
A range of interventions, including exercise and animal therapy, can help those with mild depressive symptoms, researchers say.
Â
Retinal damage ‘might signal risk’ for dementia and death
An observational study finds a dose-dependent association with retinopathy severity.
No evidence on MRI that intensive BP control cuts Alzheimer’s risk: study
Further results from the SPRINT MIND trial show a 'counterintuitive' association with decreased hippocampal volume.
Neuroinflammation common in familial frontotemporal dementia
The findings bring hope that drugs that reduce neuroinflammation might be beneficial, researchers say.
Retinal imaging may predict familial Alzheimer’s disease
Study in a Colombian kindred with a dominant mutation showed pathology visible in patients' 30s
Coroner calls for laws forcing doctors to make fitness-to-drive reports
The recommendation follows another road death involving an elderly driver with dementia.
‘Multifaceted pathology’ underlies dementia in chronic traumatic encephalopathy
Head impacts and atherosclerosis both likely have an effect on risk, researchers say.
